Effects of Exercise in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.

For people living with amyotrophic lateral sclerosis (ALS), a progressive neurological disease that weakens muscles over time, exercise has long been debated: could physical activity help preserve function, or might it push already stressed muscles too hard? This review pooled results from seven randomized controlled trials involving 322 patients to compare structured exercise programs against no exercise or usual care. Across the pooled evidence, patients who exercised showed better functional ability over the longer term and a modest improvement in a measure of lung function called forced vital capacity. Endurance or aerobic exercise specifically was linked to better functional scores. No significant difference was found in muscle strength or quality of life, and exercise did not appear to worsen fatigue or cause adverse events.

Still, this is a modest evidence base built from a small number of trials, so the findings, while encouraging, should be read as an early signal rather than settled proof of benefit for muscle strength or wellbeing outcomes.

If you or someone you know is living with ALS, a disease that gradually weakens the body's muscles, you may wonder whether staying physically active helps or could cause harm. This review looked at seven small studies involving a total of 322 patients with ALS to see what happens when people follow structured exercise programs compared with usual care alone. The combined results suggest that exercise was linked to better day-to-day functional ability over time and a small improvement in breathing capacity, measured by a test of lung function.

Aerobic or endurance-type exercise in particular was tied to better functional scores. There was no clear difference in muscle strength or in overall quality of life between those who exercised and those who did not.

Importantly, exercise did not seem to make fatigue worse or lead to reported harm in these studies. Because the total number of trials and participants was still fairly small, these results are a hopeful early signal rather than a definitive answer, and more research would help confirm how much benefit exercise truly offers.

This is a summary of research, not medical advice. Talk to your own healthcare provider about anything affecting your care.

This systematic review and meta-analysis pooled seven randomized controlled trials (322 patients with ALS) comparing structured exercise interventions against no exercise or usual care, evaluating functional ability, pulmonary function, quality of life, muscle strength, fatigue, and adverse events. Long-term functional scores were significantly higher in the exercise group (standardized mean difference 0.47, 95% CI 0.08 to 0.86, P = 0.02), and forced vital capacity percentage predicted was modestly improved (mean difference 1.71, 95% CI 0.10 to 3.31, P = 0.04).

Subgroup analysis indicated endurance or aerobic exercise specifically improved functional scores (standardized mean difference 0.36, 95% CI 0.04 to 0.68, P = 0.03). No statistically significant difference was detected for muscle strength or quality of life outcomes, and no aggravation of fatigue or adverse events was reported across included trials. However, the evidence synthesis rests on only seven trials with a moderate combined sample size, and the abstract does not detail heterogeneity or risk-of-bias grading, which limits confidence in the magnitude and consistency of pooled effects.

Clinicians should interpret these findings as indicating a plausible but not firmly established functional and pulmonary benefit, with reassuring but unverified safety signals given the absence of formal safety endpoints beyond adverse event reporting.